{"drug_name": "Perjeta", "description": "\nPERTUZUMAB (per TOOZ ue mab) treats breast cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells. It is a monoclonal antibody.\nThis medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.\nCOMMON BRAND NAME(S): PERJETA\n", "side_effects": "\nSide effects that you should report to your care team as soon as possible:\nAllergic reactions or angioedema\u2014skin rash, itching or hives, swelling of the face, eyes, lips, tongue, arms, or legs, trouble swallowing or breathing\nHeart failure\u2014shortness of breath, swelling of the ankles, feet, or hands, sudden weight gain, unusual weakness or fatigue\nInfusion reactions\u2014chest pain, shortness of breath or trouble breathing, feeling faint or lightheaded\nSide effects that usually do not require medical attention (report to your care team if they continue or are bothersome):\nDiarrhea\nDry skin\nFatigue\nHair loss\nNausea\nVomiting\nThis list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.\n", "monitoring": "\nYour condition will be monitored carefully while you are receiving this medication.\nThis medication may make you feel generally unwell. This is not uncommon as chemotherapy can affect healthy cells as well as cancer cells. Report any side effects. Continue your course of treatment even though you feel ill unless your care team tells you to stop.\nTalk to your care team if you may be pregnant. Serious birth defects can occur if you take this medication during pregnancy and for 7 months after the last dose. You will need a negative pregnancy test before starting this medication. Contraception is recommended while taking this medication and for 7 months after the last dose. Your care team can help you find the option that works for you.\nDo not breastfeed while taking this medication and for 7 months after the last dose.\n"}